Journal of Cardiac Failure
Volume 12, Issue 6 , Pages 407-412 , August 2006

Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure

  • Lynne Warner Stevenson, MD

      Affiliations

    • From the Brigham and Women's Hospital, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Lynne Warner Stevenson, MD, Advanced Heart Disease Section, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.
    • ,
  • Akshay S. Desai, MD

      Affiliations

    • Harvard Medical School, Boston, Massachusetts

Received 28 March 2006 ,Revised 2 June 2006 ,Accepted 2 June 2006.

References 

  1. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993;88:2953–2961
  2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158
  5. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation. 2006;113:776–782
  6. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760–3765
  7. Josephson M, Wellens HJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109:2685–2691
  8. Teuteberg JJ, Lewis EF, Nohria A, Tsang S, Fang J, Givertz M, et al. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Failure. 2006;i12:47–53
  9. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc. 2005;80:232–237
  10. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488
  11. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA. 2004;292:2874–2879
  12. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235
  13. Weintraub JR, Semigran MJ, Tsang S, Eramo K, Brooks K, Camuso J, et al. What do patients know about ICDs. [abstract] Heart Rhythm. 2006;3(Suppl):S139

 Dr. Stevenson is a consultant for Medtronics Inc. Dr. Desai has no potentially relevant conflicts.

PII: S1071-9164(06)00278-8

doi: 10.1016/j.cardfail.2006.06.001

Journal of Cardiac Failure
Volume 12, Issue 6 , Pages 407-412 , August 2006

Article Tools

* Image Usage & Resolution